Cargando…
Associations between CES1 variants and dosing and adverse effects in children taking methylphenidate
BACKGROUND: Methylphenidate is the most prescribed stimulant to treat attention deficit-hyperactivity disorder (ADHD). Despite its widespread usage, a fair proportion of children are classified as non-responders to the medication. Variability in response and occurrence of adverse events with methylp...
Autores principales: | Brown, Jacob T., Beery, Nancy, Taran, Allise, Stevens, Tyler, Henzler, Christine, Badalamenti, Jonathan, Regal, Ron, McCarty, Catherine A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9890192/ https://www.ncbi.nlm.nih.gov/pubmed/36741090 http://dx.doi.org/10.3389/fped.2022.958622 |
Ejemplares similares
-
CES1 and SLC6A2 Genetic Variants As Predictors of Response To Methylphenidate in Autism Spectrum Disorders
por: Hernandez, Marta H, et al.
Publicado: (2022) -
Psychosis Induced by Methylphenidate in Children and Young Patients With Attention-Deficit Hyperactivity Disorder
por: Pasha, Khadija, et al.
Publicado: (2023) -
Population Pharmacokinetics of Methylphenidate in Healthy Adults Emphasizing Novel and Known Effects of Several Carboxylesterase 1 (CES1) Variants
por: Lyauk, YK, et al.
Publicado: (2016) -
Efficacy of Cognitive Behavioral Therapy and Methylphenidate in the Treatment of Attention Deficit Hyperactivity Disorder in Children and Adolescents: A Systematic Review
por: Ojinna, Blessing T, et al.
Publicado: (2022) -
Clevidipine resistance in a patient taking aripiprazole and methylphenidate
por: Jacklen, M Alysse, et al.
Publicado: (2014)